Видео ютуба по тегу Anthracyclines

Anthracyclines: The Most Useful and Probably Most Hated Drugs in Treating Cancer Patients
Anthracyclines: The Most Useful and Probably Most Hated Drugs in Treating Cancer Patients
Кардиотоксичность антрациклинов: роль кардиоонкологии в лечении
Кардиотоксичность антрациклинов: роль кардиоонкологии в лечении
Pharmacology - Chemotherapy agents (MOA, Alkalating, antimetabolites, topoisomerase, antimitotic)
Pharmacology - Chemotherapy agents (MOA, Alkalating, antimetabolites, topoisomerase, antimitotic)
Anthracyclines for HER2-Positive Early Breast Cancer
Anthracyclines for HER2-Positive Early Breast Cancer
Dr. Hurvitz on Eliminating Anthracyclines in HER2+ Breast Cancer Treatment
Dr. Hurvitz on Eliminating Anthracyclines in HER2+ Breast Cancer Treatment
Anthracyclines Can Cause What In The Heart?
Anthracyclines Can Cause What In The Heart?
Beyond anthracyclines and trastuzumab: cardiotoxicity of novel agents
Beyond anthracyclines and trastuzumab: cardiotoxicity of novel agents
Can anthracyclines be omitted in TNBC?
Can anthracyclines be omitted in TNBC?
Should Anthracyclines Be Given in Advanced Gastroesophageal Cancer?
Should Anthracyclines Be Given in Advanced Gastroesophageal Cancer?
SAFE: cardiotoxicity prevention in breast cancer treated with anthracyclines and/or trastuzumab
SAFE: cardiotoxicity prevention in breast cancer treated with anthracyclines and/or trastuzumab
EBCC 7: Ways to predict efficacy of anthracyclines
EBCC 7: Ways to predict efficacy of anthracyclines
Episode 296: Pharmacology 101: Anthracyclines and Other Antitumor Antibiotics
Episode 296: Pharmacology 101: Anthracyclines and Other Antitumor Antibiotics
Dr. Durand on Anthracyclines in Treatments for HER2+ Breast Cancer
Dr. Durand on Anthracyclines in Treatments for HER2+ Breast Cancer
ANTHRACYCLINES :MECANISM OF ACTION AND CARDIOTOXICITY Pr Fatiha ATIF
ANTHRACYCLINES :MECANISM OF ACTION AND CARDIOTOXICITY Pr Fatiha ATIF
GCOS2025: Managing Hypertension in Cancer — Anthracyclines, VEGF, TKIs | Prof Ninian Lang
GCOS2025: Managing Hypertension in Cancer — Anthracyclines, VEGF, TKIs | Prof Ninian Lang
Dr. Tripathy on the Treatment of Breast Cancer With Anthracyclines and Trastuzumab
Dr. Tripathy on the Treatment of Breast Cancer With Anthracyclines and Trastuzumab
SABCS 2023: Debate - Anthracyclines, to give or not to give
SABCS 2023: Debate - Anthracyclines, to give or not to give
Debate: Does epi still have pep? Are anthracyclines dead in GI cancers? - Yes
Debate: Does epi still have pep? Are anthracyclines dead in GI cancers? - Yes
Anthracycline Cardiotoxicity: Clinical Types
Anthracycline Cardiotoxicity: Clinical Types
Debate: Does epi still have pep? Are anthracyclines dead in GI cancers? - No
Debate: Does epi still have pep? Are anthracyclines dead in GI cancers? - No
Mechanism of Antitumor Antibiotics (Anthracycline) | Clinical Uses | Adverse Effects
Mechanism of Antitumor Antibiotics (Anthracycline) | Clinical Uses | Adverse Effects
Anthracyclines, Taxanes, Vinca Alkaloids, and Epothilones
Anthracyclines, Taxanes, Vinca Alkaloids, and Epothilones
Anthracyclines, Taxanes, Vinca Alkaloids, Epothilones, and Epipodophyllotoxins
Anthracyclines, Taxanes, Vinca Alkaloids, Epothilones, and Epipodophyllotoxins
Mechanism-based Serum Peptidomic Study in Anthracycline Cardiotoxicity Prevention
Mechanism-based Serum Peptidomic Study in Anthracycline Cardiotoxicity Prevention
What Are Anthracyclines? - The Disease Encyclopedia
What Are Anthracyclines? - The Disease Encyclopedia